M&A within the life sciences sector continues to be very active for consulting and technology companies. Along with recent attention-grabbing acquisitions, such as AmeriesourceBergen’s purchase of PharamaLex for $1.3bn in September 2022, there have been plenty of other trade deals, as well as many companies attracting investment from private equity.
Fri Nov 11, 2022